The deal for Rio Health, a leading health producer in the developing world, comes as the Japanese conglomerate moves into a much bigger market with its acquisition of the popular Vita brand.
The company announced the acquisition on Wednesday, saying that the deal would allow it to expand its product lineup and expand its operations in the United States.
The deal will also enable the Rio group to further grow its portfolio of health products and services, which include the brand and the VITA Health products.
It will also allow the Rio Health Group to become a leader in the emerging field of health delivery technologies and services in the Americas and the Caribbean region, Rio said in a statement.
The Rio group has long been one of the leaders in the development of health technology.
Its brands include the VETA and VITAK brands, and it has been a leader of the development and manufacturing of products and processes for a wide range of diseases, from HIV/AIDS treatment to cardiac rehabilitation, in many countries.
Rio said it would continue to focus on developing and delivering health care solutions for a global population that is increasingly dependent on modern healthcare systems.
The acquisition of Viacoms health products is the largest acquisition by a Japanese conglomerate in its history.
Rio said it will continue to leverage its existing strategic partnerships with other leading health companies.
The news comes amid rising tensions between the United Kingdom and the U.S. over North Korea’s nuclear program and the United Nations and the European Union’s sanctions on North Korea.
Rome, Rio and ViacOM will be led by President Donald Trump’s son-in-law, Jared Kushner.
The companies are also expected to expand their operations in Brazil, which has been an economic powerhouse for Rio and other global health companies in recent years.
Rousseff, the wife of former President Michel Temer, said that she was very pleased to see Rio Health join the consortium and to work with Viacomo.RIO said it is investing $1 billion in the project, and will expand its health business globally.